Biolinerx (BLRX) Posts Q1 Loss of 1c/Share

Biolinerx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Biolinerx (BLRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• C.H. Robinson acquires DeSpir Logistics for $75 million